Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to ...

North America and Western Europe — two wealthier regions of the world — reported the highest incidences and are projected to ...

Sun Pharmaceutical Industries on Monday said it has launched its global innovative drug ILUMYA in India for the treatment of ...

Sun Pharma's managing director, Kirti Ganorkar, said Ilumya is already available in 35 countries and has consistently ...

Innovent's Pecondle, a recombinant anti-interleukin-23p19 subunit, receives China NMPA approval to treat moderate-to-severe plaque psoriasis: San Francisco Monday, December 1, 202 ...

A Johns Hopkins Medicine study involving a dozen people with the inflammatory skin disease hidradenitis suppurativa (HS), ...

Sun Pharmaceutical Industries announced the launch of its global innovative drug, ILUMYA (Tildrakizumab) in India for moderate-to-severe plaque psoriasis. A novel biologic treatment, ILUMYA has been ...

Mumbai-based Sun Pharma has introduced its global innovative biologic Ilumya (Tildrakizumab) in India for the treatment of moderate-to-seve.

Dry winter skin? Nutritionist Anushi Jain lists fruits, veggies, and healthy fats that help hydrate, repair, and keep skin ...

A Johns Hopkins Medicine study involving a dozen people with the inflammatory skin disease hidradenitis suppurativa (HS), ...

Medical Beauty Lasers Market projected to reach USD 7,955.0 Mn by 2035, growing at a 8.3% CAGR — driven by rising demand for ...